In video 1 of this three-part series, learn about the relevance of real-world evidence in COPD with underlying type 2 inflammation and how it can complement phase 3 clinical trial findings, with pulmonologist Dr. Mustafa Abdo.
In video 2 of this three-part series, learn about the rationale for a German real-world study of dupilumab in patients with COPD and underlying type 2 inflammation, and how it aims to complement clinical trial evidence, with pulmonologist Dr. Mustafa Abdo.
Professors Matthias Augustin and Sarina Elmariah evaluate how targeted therapies transform the management of prurigo nodularis, addressing the itch-scratch cycle and broader manifestations such as lesions.

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.